RxSight (RXST) Receivables - Net (2020 - 2025)
Historic Receivables - Net for RxSight (RXST) over the last 6 years, with Q3 2025 value amounting to $24.2 million.
- RxSight's Receivables - Net fell 479.74% to $24.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $24.2 million, marking a year-over-year decrease of 479.74%. This contributed to the annual value of $30.0 million for FY2024, which is 4816.82% up from last year.
- Latest data reveals that RxSight reported Receivables - Net of $24.2 million as of Q3 2025, which was down 479.74% from $28.1 million recorded in Q2 2025.
- RxSight's Receivables - Net's 5-year high stood at $31.0 million during Q1 2025, with a 5-year trough of $3.9 million in Q2 2021.
- Moreover, its 5-year median value for Receivables - Net was $14.3 million (2023), whereas its average is $16.3 million.
- In the last 5 years, RxSight's Receivables - Net soared by 12533.94% in 2022 and then plummeted by 479.74% in 2025.
- RxSight's Receivables - Net (Quarter) stood at $4.9 million in 2021, then soared by 125.34% to $11.0 million in 2022, then soared by 85.11% to $20.3 million in 2023, then surged by 48.17% to $30.0 million in 2024, then dropped by 19.63% to $24.2 million in 2025.
- Its last three reported values are $24.2 million in Q3 2025, $28.1 million for Q2 2025, and $31.0 million during Q1 2025.